Effect of Xuanfei Zhisou Prescription on IL-17 Signaling Pathway in COPD Model Rats
|更新时间:2024-04-16
|
Effect of Xuanfei Zhisou Prescription on IL-17 Signaling Pathway in COPD Model Rats
“Progress has been made in the study of the effect of Xuanfei Zhisou formula on the interleukin-17 signaling pathway in chronic obstructive pulmonary disease model rats, providing a new treatment plan for COPD.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 9, Pages: 28-39(2024)
SHI Yanli,WANG Yunchao,YANG Zhen,et al.Effect of Xuanfei Zhisou Prescription on IL-17 Signaling Pathway in COPD Model Rats[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(09):28-39.
SHI Yanli,WANG Yunchao,YANG Zhen,et al.Effect of Xuanfei Zhisou Prescription on IL-17 Signaling Pathway in COPD Model Rats[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(09):28-39. DOI: 10.13422/j.cnki.syfjx.20240318.
Effect of Xuanfei Zhisou Prescription on IL-17 Signaling Pathway in COPD Model Rats
Mechanism of Macrophage Polarization in COPD Immunoinflammation Based on Theory of Yin-Yang Balance
Modern Research and Application Characteristics of Inhalation Treatment for Chronic Lung Diseases
Evaluation of Animal Models of Chronic Obstructive Pulmonary Disease Based on Clinical Characteristics in Traditional Chinese and Western Medicine
Connotation of Traditional Chinese Medicine's Protection of Pulmonary Microvascular Endothelial Cells in Prevention and Treatment of Chronic Obstructive Pulmonary Disease Based on "Lung Collateral Theory"
Related Author
WU Dongsheng
LI Ruijie
WANG Tongtong
WU Haoran
ZHANG Jun
ZHANG Wei
LIN Xiangke
MAO Zhiguo
Related Institution
Institute of Infectious Diseases, Shanghai Institute of TCM
Baoshan Hospital of Shanghai University of TCM
Shuguang Hospital of Shanghai University of Traditional Chinese Medicine(TCM)
The First Hospital of Hunan University of Chinese Medicine